Contrasting roles for nitric oxide and peroxynitrite in the peroxidation of myelin lipids

Journal of Neuroimmunology

Volumn 95, Issue 1-2, 1999, Pages 1-7

  Van Der Veen, Roel C ^a   Roberts, L Jackson ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

Experimental allergic encephalomyelitis; Isoprostanes; Myelin; Nitric oxide; Peroxynitrite

Indexed keywords

ISOPROSTANE; LIPID; NEUROPROSTANE; NITRIC OXIDE; PEROXYNITRITE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ENZYME ACTIVITY; LIPID PEROXIDATION; MOUSE; MULTIPLE SCLEROSIS; MYELINATION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; REACTION ANALYSIS;

ANIMALS; CENTRAL NERVOUS SYSTEM; DINOPROST; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; F2-ISOPROSTANES; LIPID PEROXIDATION; MICE; MOLSIDOMINE; MYELIN PROTEINS; MYELIN SHEATH; NITRATES; NITRIC OXIDE; NITRIC OXIDE DONORS; OXIDANTS; PENICILLAMINE;

EID: 0033103663     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00239-2     Document Type: Article

References (50)

1. Beckman J.S. Peroxynitrite versus hydroxyl radical: the role of nitric oxide in superoxide-dependent cerebral injury. Ann. New York Acad. Sci. 738:1994;69-75.
2. Bo L., Dawson T.M., Wesselingh S., Mork S., Choi S., Kong P.A., Hanley D., Trapp B.D. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann. Neurol. 36:1994;778-786.
3. Bolanos J.P., Heales S.J., Land J.M., Clark J.B. Effect of peroxynitrite on the mitochondrial respiratory chain: differential susceptibility of neurones and astrocytes in primary culture. J. Neurochem. 64:1995;1965-1972.
4. Bongarzone E.R., Pasquini J.M., Soto E.F. Oxidative damage to proteins and lipids of CNS myelin produced by in vitro generated reactive oxygen species. J. Neurosci. Res. 41:1995;213-221.
5. Bourre J.M., Pascal G., Durand G., Masson M., Dumont O., Piciotti M. Alterations in the fatty acid composition of rat brain cells (neurons, astrocytes, and oligodendrocytes) and of subcellular fractions (myelin and synaptosomes) induced by a diet devoid of n-3 fatty acids. J. Neurochem. 43:1984;342-348.
6. Brenner T., Brocke S., Szafer F., Sobel R.A., Parkinson J.F., Perez D.H., Steinman L. Inhibition of nitric oxide synthase for treatment of experimental autoimmune encephalitis. J. Immunol. 158:1997;2940-2946.
7. Brett R., Rumsby M.G. Susceptibility of myelin glycerophospholipids and sphingolipids to oxidative attack by hydroxyl free radicals as measured by the thiobarbituric acid test. Neurochem. Int. 24:1993;241-251.
8. Cross A.H., Misko T.P., Lin R.F., Hickey W.F., Trotter J.L., Tilton R.G. Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J. Clin. Invest. 93:1994;2684-2690.
9. Darley-Usmar V.M., Hogg N., O'Leary V.J., Wilson M.T., Moncada S. The simultaneous generation of superoxide and nitric oxide can initiate lipid peroxidation in human low density lipoprotein. Free Radic. Res. Commun. 17:1992;9-20.
10. Fenyk-Melody J.E., Garrison A.E., Brunnert S.R., Weidner J.R., Shen F., Shelton B.A., Mudgett J.S. Experimental autoimmune encephalomyelitis is exacerbated in mice lacking the NOS2 gene. J. Immunol. 160:1998;2940-2946.
11. Fisher M., Plante G.M., Doyle E.M. Inhibition of inflammatory cell-mediated oxidation and interleukin-1β generation by a 21-aminosteroid, U74500A. J. Neurol. Sci. 119:1993;189-194.
12. 2 of cytokine-elicited nitric oxide synthesis in rat liver macrophages. Biol. Chem. Hoppe-Seyler. 373:1992;897-902.
13. Gold D.P., Schroder K., Powell H.C., Kelly C.J. Nitric oxide and the immunomodulation of experimental allergic encephalomyelitis. Eur. J. Immunol. 27:1997;2863-2869.
14. Halliwell, B., Gutteridge, J.M.C., 1995. Free Radicals in Biology and Medicine. Clarendon Press, Oxford.
15. Hogg N., Kalyanaraman J.J., Struck A., Parthasarathy S. Inhibition of low-density lipoprotein oxidation by nitric oxide. Eur. Biochem. Soc. 334:1993;170-174.
16. Hogg, N., Kalyanaraman, B., Darley-Usmar, V., 1995. Oxidant and antioxidant effects of nitric oxide and superoxide in the vasculature. In: Davies, K.J.A., Ursini, F. (Eds.), The Oxygen Paradox. Cleup University Press, Padora, Italy, pp. 317-324.
17. Hooper D.C., Ohnishi S.T., Kean R., Numagami Y., Dietzschold B., Koprowski H. Local nitric oxide production in viral and autoimmune diseases of the central nervous system. Proc. Natl. Acad. Sci. U.S.A. 92:1995;5312-5316.
18. Hooper D.C., Bagasra O., Marini J.C., Zborek A., Ohnishi S.T., Kean R., Champion J.M., Sarker A.B., Bobroski L., Farber J.L., Akaike T., Maeda H., Koprowski H. Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis. Proc. Natl. Acad. Sci. U.S.A. 94:1997;2528-2533.
19. Imai T., Hirata Y., Kanno K., Marumo F. Induction of nitric oxide synthase by cyclic AMP in rat vascular smooth muscle cells. J. Clin. Invest. 93:1994;543-549.
20. Jessup W., Mohr D., Gieseg S.P., Dean R.T., Stocker R. The participation of nitric oxide in cell-free and its restriction of macrophage-mediated oxidation of low-density lipoprotein. Biochim. Biophys. Acta. 1180:1992;73-82.
21. Konat G.W., Wiggins R.C. Effect of reactive species on myelin membrane proteins. J. Neurochem. 45:1985;1113-1118.
22. Kubes P., Kurose I., Granger D.N. NO donors prevent integrin-induced leukocyte adhesion but not P-selection-dependent rolling in post-ischemic venules. Am. J. Physiol. 267:1994;H931-937.
23. Langermans J.A.M., van der Hulst M.E.B., Nibbering P.H., Hiemstra P.S., Fransen L., van Furth R. IFN-γ-induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous tumor necrosis factor-α J. Immunol. 148:1992;568-574.
24. Ludowyk P.A., Hughes W., Hugh A., Willenborg D.O., Rockett K.A., Parish C.R. Astrocytic hypertrophy: an important pathological feature of chronic experimental autoimmune encephalitis in aged rats. J. Neuroimmunol. 48:1993;121-134.
25. Marletta M.A. Nitric oxide synthase structure and mechanism. J. Biol. Chem. 268:1993;12231-12234.
26. Matthys P., Froyen G., Verdot L., Huang S., Sobis H., van Damme J., Vray B., Aguet M., Billiau A. IFN-y receptor-deficient mice are hypersensitive to the anti-CD3-induced cytokine release syndrome and thymocyte apoptosis. Protective role of endogenous nitric oxide. J. Immunol. 155:1995;3823-3829.
27. Merrill J.E., Ignarro L.J., Sherman M.P., Melinek J., Lane T.E. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol. 151:1993;2132-2141.
28. Miles A.M., Bohle D.S., Glassbrenner P.A., Hansert B., Wink D.A., Grisham M.B. Modulation of superoxide-dependent oxidation of hydroxylation reactions by nitric oxide. J. Biol. Chem. 271:1996;40-47.
29. Mills C.D. Molecular basis of 'suppressor' macrophages. Arginine metabolism via the nitric oxide synthetase pathway. J. Immunol. 146:1991;2719-2723.
30. Misko T.P., Trotter J.L., Cross A.H. Mediation of inflammation by encephalitogenic cells: interferon-γ induction of nitric oxide synthase and cyclooxygenase 2. J. Neuroimmunol. 61:1995;195.
31. Mitrovic B., Ignarro L.J., Montestruque S., Smoll A., Merrill J.E. Nitric oxide as a potential pathological mechanism in demyelination: its differential effects on primary glial cells in vitro. Neuroscience. 61:1994;575-585.
32. 2-isoprostanes produced by non-cyclooxygenase free radical-catalyzed mechanism. Methods Enzymol. 233:1994;163-174.
33. Norton W.T., Poduslo S.E. Myelination in rat brain: method of myelin isolation. J. Neurochem. 21:1973;749-757.
34. 3H ]GABA release from cerebral cortical neurons is mediated by peroxynitrite J. Neurochem. 65:1995;1109-1114.
35. Okyda Y., Nakatsuji Y., Fujimura H., Esumi H., Ogura T., Yanagihara T., Sakoda S. Expression of the inducible isoform of nitric oxide synthase in the central nervous system of mice correlates with the severity of actively induced experimental allergic encephalomyelitis. J. Neuroimmunol. 62:1995;103.
36. Radi R., Beckman J.S., Bush K.M., Freeman B.A. Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch. Biochem. Biophys. 288:1991;481-487.
37. Roberts L.J., Morrow J.P. Generation and action of isoprostanes. Biochem. Biophys. Acta. 1345:1997;121-135.
38. Roberts, L.J., Morrow, J.D., 1998. Formation of novel isoprostane-like compounds from docosahexanoic acid. Proc. 4th Int. Conf. Essential Fatty Acids Eicosanoids. ADCS press, Champaign, IL.
39. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:1993;801-809.
40. Ruuls S.R., van der Linden S., Sontrop K., Huitinga I., Dijkstra C.D. Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors. Clin. Exp. Immunol. 103:1996;467-474.
41. Sahrbacher U.C., Lechner F., Eugster H.P., Frei K., Lassmann H., Fontana A. Mice with an inactivation of the inducible nitric oxide synthase gene are susceptible to experimental autoimmune encephalomyelitis. Eur. J. Immunol. 28:1998;1332-1338.
42. Szabo C., Zingarelli B., O'Connor M., Salzman A.L. DNA strand breakage, activation of poly (ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity in macrophages and smooth muscle cells exposed to peroxynitrite. Proc. Natl. Acad. Sci. U.S.A. 93:1996;1753-1758.
43. 2 alpha, in the rat: evidence for interaction with thromboxane A2 receptors. J. Clin. Invest. 90:1992;136-141.
44. Tomioka H., Saito H. Characterization of immunosuppressive functions of murine peritoneal macrophages induced with various agents. J. Leukocyte Biol. 51:1991;24-31.
45. Tuohy V.K., Zhijian L., Sobel R.A., Laursen R.A., Lees M.B. Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice. J. Immunol. 142:1989;1523-1527.
46. van der Veen R.C., Hinton D.R., Incardonna F., Hofman F.M. Extensive peroxynitrite activity during progressive stages of central nervous system inflammation. J. Neuroimmunol. 77:1997;1-7.
47. Winrow V.R., Winyard P.G., Morris C.J., Blake D.R. Free radicals in inflammation: second messengers and mediators of tissue destruction. Br. Med. Bull. 49:1993;506-522.
48. Zhao W., Tilton R.G., Corbett J.A., McDaniel M.L., Misko T.P., Williamson J.R., Cross A.H., Hickey W.F. Experimental allergic encephalomyelitis in the rat is inhibited by aminoguanidine, an inhibitor of nitric oxide synthase. J. Neuroimmunol. 64:1996;123-133.
49. Zielasek J., Jung S., Gold R., Liew F.Y., Toyka K.V., Hartung H.P. Administration of nitric oxide synthase inhibitors in experimental autoimmune neuritis and experimental autoimmune encephalomyelitis. J. Neuroimmunol. 58:1995;81-88.
50. Zingarelli B., O'Connor M., Wong H., Salzman A.L., Szabo C. Peroxynitrite-mediated DNA stand breakage activates poly-adenosine diphosphate ribosyl synthetase and causes cellular energy depletion in macrophages stimulated with bacterial lipopolysaccharide. J. Immunol. 156:1996;350-358.